Skip to content
  • Home
  • Board of Directors
  • 16th Symposium
    • Scientific Program
    • Posters Presentation
    • Registration fees
  • Knowledge Center
    • Guidelines
      • Clinical
      • Legal and Regulatory
    • Articles
      • Bone marrow cell therapy
      • Colony-stimulating factors therapy
      • Myoblast therapy
      • Preclinical research
      • Regulatory texts
      • Reviews
    • Books
    • Research
      • By clinical setting
  • Tecam
    • Past Symposia
    • TECAM Faculty
    • Photo Gallery
  • Upcoming Events
    • 2014 Events
    • 2013 Events
    • 2012 Events
    • 2011 Events
  • Links
  • Contact
person_outline
search
share email print
adminAuthor website
  • Guidelines, Legal and Regulatory, Official Journal of the European Union
  • 18 February, 2003

COMMISSION DIRECTIVE 2003/94/EC of 8 October 2003

  • dir_2003_94_en.pdf
  • Journal Official Journal of the European Union
  • Year 2003

Laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use

Cardiovascularcelltherapy
carlos3
ter
complutense
ifm
gregorio-maranon
igm
logo
logo

Download APP


Facebook Posts

This message is only visible to admins.

Problem displaying Facebook posts.
Click to show error

Error: An access token is required to request this resource.
Type: OAuthException
Solution: See here for how to solve this error
Follow us on: facebook twitter
more_vert
© 2015 Cadiovascular Cell Therapy Developed by Trama Solutions